Center-Authored Papers

Filters: Author is Yee, C  [Clear All Filters]
2018
Paulson KG, Voillet V, McAfee MS, Hunter DS, Wagener FD, Perdicchio M, Valente WJ, Koelle SJ, Church CD, Vandeven N et al..  2018.  Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.. Nature communications. 9(1):3868. Abstract
2017
Chapuis AG, Desmarais C, Emerson R, Schmitt TM, Shibuya K, Lai I, Wagener F, Chou J, Roberts IM, Coffey DG et al..  2017.  Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8(+) T Cells In Vivo.. Science immunology. 2(8) Abstract
2016
Chapuis AG, Roberts IM, Thompson JA, Margolin KA, Bhatia S, Lee SM, Sloan HL, Lai IP, Farrar EA, Wagener F et al..  2016.  T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(31):3787-3795. Abstract
Chapuis AG, Lee SM, Thompson JA, Roberts IM, Margolin KA, Bhatia S, Sloan HL, Lai I, Wagener F, Shibuya K et al..  2016.  Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.. The Journal of experimental medicine. 213(7):1133-9. Abstract
2014
Noh KH, Kim S-H, Kim JH, Song K-H, Lee Y-H, Kang TH, Han HD, Sood AK, Ng J, Kim K et al..  2014.  API5 Confers Tumoral Immune Escape through FGF2-Dependent Cell Survival Pathway.. Cancer research. 74(13):3556-66. Abstract
Chapuis AG, Afanasiev OK, Iyer JG, Paulson KG, Parvathaneni U, Hwang JH, Lai I, Roberts IM, Sloan HL, Bhatia S et al..  2014.  Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.. Cancer immunology research. 2(1):27-36. Abstract
Yee C.  2014.  The use of endogenous T cells for adoptive transfer.. Immunological reviews. 257(1):250-63. Abstract
Shibuya KC, Goel VK, Xiong W, Sham JG, Pollack SM, Leahy AM, Whiting SH, Yeh MM, Yee C, Riddell SR et al..  2014.  Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment.. PloS one. 9(5):e96565. Abstract
Pollack SM, Jones RL, Farrar EA, Lai IP, Lee SM, Cao J, Pillarisetty VG, Hoch BL, Gullett A, Bleakley M et al..  2014.  Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells.. Journal for immunotherapy of cancer. 2(1):36. Abstract
2013
Chapuis AG, Ragnarsson GB, Nguyen HN, Chaney CN, Pufnock JS, Schmitt TM, Duerkopp N, Roberts IM, Pogosov GL, Ho WY et al..  2013.  Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.. Science translational medicine. 5(174):174ra27. Abstract
Goodridge JP, Lee N, Burian A, Pyo C-W, Tykodi SS, Warren EH, Yee C, Riddell SR, Geraghty DE.  2013.  HLA-F and MHC-I Open Conformers Cooperate in a MHC-I Antigen Cross-Presentation Pathway.. Journal of immunology (Baltimore, Md. : 1950). 191(4):1567-77. Abstract
Lim SA, Kim T-J, Lee JE, Sonn CH, Kim K, Kim J, Choi JG, Choi I-K, Yun C-O, Kim J-H et al..  2013.  Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.. Cancer research. 73(8):2598-607. Abstract
2012
Pollack SM, Jungbluth AA, Hoch BL, Farrar EA, Bleakley M, Schneider DJ, Loggers ET, Rodler E, Eary JF, Conrad EU et al..  2012.  NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.. Cancer. 118(18):4564-70. Abstract
Chapuis AG, Thompson JA, Margolin KA, Rodmyre R, Lai IP, Dowdy K, Farrar EA, Bhatia S, Sabath DE, Cao J et al..  2012.  Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.. Proceedings of the National Academy of Sciences of the United States of America. 109(12):4592-7. Abstract
Robins HS, Desmarais C, Matthis J, Livingston R, Andriesen J, Reijonen H, Carlson CS, Nepom G, Yee C, Cerosaletti K.  2012.  Ultra-sensitive detection of rare T cell clones.. Journal of immunological methods. 375(1-2):14-19. Abstract
Lee SM, Yee C.  2012.  Another LAP in the Race.. Cancer discovery. 2(2):107-9. Abstract
Chou J, Voong LN, Mortales CL, Towlerton AMH, Pollack SM, Chen X, Yee C, Robbins PF, Warren EH.  2012.  Epigenetic Modulation to Enable Antigen-specific T-cell Therapy of Colorectal Cancer.. Journal of immunotherapy (Hagerstown, Md. : 1997). 35(2):131-41. Abstract
Kim K, An HJ, Jun S-H, Kim T-J, Lim SA, Park G, Na HB, Park YI, Hyeon T, Yee C et al..  2012.  Single Step Isolation and Activation of Primary CD3(+) T Lymphocytes Using Alcohol-Dispersed Electrospun Magnetic Nanofibers.. Nano letters. 12(8):4018-24. Abstract
Pollack SM, Li Y, Blaisdell MJ, Farrar EA, Chou J, Hoch BL, Loggers ET, Rodler E, Eary JF, Conrad EU et al..  2012.  NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.. PloS one. 7(2):e32165. Abstract
Chapuis AG, Yee C.  2012.  Cancer ImmunotherapyMonitoring Antigen-Specific Responses in Clinical Trials of Cancer Immunotherapy. :425-453.
2011
Iyer JG, Afanasiev OK, McClurkan C, Paulson K, Nagase K, Jing L, Marshak JO, Dong L, Carter J, Lai I et al..  2011.  Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood.. Clinical cancer research : an official journal of the American Association for Cancer Research. 317(21):6671-6680. Abstract
Tanaka A, Jensen JD, Prado R, Riemann H, Shellman YG, Norris DA, Chin L, Yee C, Fujita M.  2011.  Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma.. Gene therapy. 18(8):827-34. Abstract
Weber J, Atkins M, Hwu P, Radvanyi L, Sznol M, Yee C.  2011.  White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(7):1664-73. Abstract
Pollack SM, Loggers ET, Rodler ET, Yee C, Jones RL.  2011.  Immune-based therapies for sarcoma.. Sarcoma. 2011:438940. Abstract
Pollack SM, Yee C.  2011.  Innate Immune Regulation and Cancer ImmunotherapyAdoptive Immunotherapy of Melanoma. :439-465.